Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 13;5(8):783-790.
doi: 10.1002/bco2.405. eCollection 2024 Aug.

Muscle matters: Skeletal muscle index and body mass index impact on complications and survival in renal cancer

Alexander Hintze Hillers  1   2 , Signe Wang Bach  2   3 , Atena Saito  2   4 , Nessn Azawi  2   5
Affiliations

Muscle matters: Skeletal muscle index and body mass index impact on complications and survival in renal cancer

Alexander Hintze Hillers et al. BJUI Compass. .

Erratum in

  • Erratum.
    [No authors listed] [No authors listed] BJUI Compass. 2024 Dec 30;5(12):1324-1329. doi: 10.1002/bco2.482. eCollection 2024 Dec. BJUI Compass. 2024. PMID: 39744071 Free PMC article.

Abstract

Objective: The objective of this study is to independently assess skeletal muscle index (SMI) and body mass index (BMI) as prognostic determinants for renal cell carcinoma (RCC) and investigate their correlation with surgical outcomes.

Patients and methods: A retrospective cohort study of 524 RCC patients diagnosed between August 2010 and July 2018 was conducted using data from the Zealand University Hospital Renal Cancer Database in Denmark. Patient information was extracted from electronic patient records and the National Cancer Registry and encompassed demographics, clinical factors, tumour characteristics and surgical details. SMI was calculated from a single third lumbar vertebra (L3) axial computed tomography (CT) image via CoreSlicer software and classified into high using gender-specific thresholds. Primary outcomes focused on complications within 90 days as well as survival outcomes, and their relation with both SMI and BMI. Multivariable analysis assessed SMI's independent prognostic significance in RCC.

Results: Among 524 patients, 18.5% experienced complications, with high SMI correlating significantly (p = 0.018) with a 72% higher complication risk. High SMI patients had a 22.7% complication rate compared to 14.5% in the low SMI group. High SMI was also linked to prolonged survival (110.95 vs. 94.87 months; p = 0.001), whereas BMI showed no significant survival differences (p = 0.326). Multivariable analysis (n = 522) revealed high SMI associated with improved survival (hazard ratio [HR] = 0.738; 95% CI, 0.548-0.994; p = 0.046). Advanced T-stage significantly impacted mortality (T2: HR = 2.057; T3: HR = 4.361; p < 0.001), and each additional year of age raised mortality risk by 4.3% (HR = 1.043; p < 0.001).

Conclusions: Higher SMI increases the risk of postoperative complications, yet it significantly improves overall survival rates. Different BMI categories lack RCC prognostic significance. The increasing incidence in RCC calls for the use of CT scan to assess SMI and aid treatment planning in patients who might benefit from preoperative interventions.

Keywords: body mass index (BMI); overall survival; postoperative complications; renal cell carcinoma; skeletal muscle index (SMI).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Survival time of skeletal muscle index (SMI) groups with high SMI having a bigger fraction with longer survival time.
FIGURE 2
FIGURE 2
Survival time of body mass index (BMI) groups with normal BMI.
See this image and copyright information in PMC

References

    1. Bukavina L, Bensalah K, Bray F, Carlo M, Challacombe B, Karam JA, et al. Epidemiology of renal cell carcinoma: 2022 update. Eur Urol. 2022;82(5):529–542. 10.1016/j.eururo.2022.08.019 - DOI - PubMed
    1. Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, et al. Renal cell carcinoma. Nat Rev Dis Primers. 2017;3(1):17009. 10.1038/nrdp.2017.9 - DOI - PMC - PubMed
    1. Bagheri M, Speakman JR, Shemirani F, Djafarian K. Renal cell carcinoma survival and body mass index: a dose‐response meta‐analysis reveals another potential paradox within a paradox. Int J Obes (Lond). 2016;40(12):1817–1822. 10.1038/ijo.2016.171 - DOI - PubMed
    1. Balci M, Glaser ZA, Chang SS, Herrell SD, Barocas DA, Keegan KA, et al. Differential effect of body mass index by gender on oncological outcomes in patients with renal cell carcinoma. J Cancer Res Ther. 2021;17(2):420–425. 10.4103/jcrt.JCRT_546_18 - DOI - PubMed
    1. Takemura K, Yonekura S, Downey LE, Evangelopoulos D, Heng DYC. Impact of body mass index on survival outcomes of patients with metastatic renal cell carcinoma in the immuno‐oncology era: a systematic review and meta‐analysis. Eur Urol Open Sci. 2022;39:62–71. 10.1016/j.euros.2022.03.002 - DOI - PMC - PubMed

LinkOut - more resources